Open Outbreak

Hepatitis E

Also known as: HEV, hepatitis E virus

Hepatitis E is a liver infection caused by the hepatitis E virus, or HEV. It occurs worldwide. Large outbreaks often begin when drinking water becomes contaminated with human waste, especially where sanitation has broken down or people have been displaced. Some types of the virus also pass from animals to people through uncooked or undercooked meat. Many infections cause no symptoms or a mild illness. Others cause fever, nausea, abdominal pain and jaundice, meaning yellow skin or eyes. Most infections resolve on their own, but some cause sudden liver failure. Pregnant women, particularly late in pregnancy, face a much higher risk of severe illness and death. People whose immune systems are suppressed can occasionally develop long-lasting infection. Safe drinking water, sanitation, hand hygiene and safer food preparation are important preventive measures. A vaccine is licensed in China and other countries and has been used during outbreaks. There is no specific antiviral treatment that changes the course of ordinary acute hepatitis E; severe illness requires hospital care.

Key facts

TransmissionMainly through drinking water contaminated with infected people's stools. Some virus types spread from animals through uncooked or undercooked meat.
Incubation2–10 weeks; average 5–6 weeks, according to WHO.
Case fatalityWHO's 2024 Chad notice describes general lethality of 0.5–4%. WHO's fact sheet reports mortality up to 20–25% among women infected in the third trimester of pregnancy. Separate treated and untreated estimates are unknown from the retrieved sources.
Reproduction numberunknown
VaccineA preventive vaccine is licensed in China and other countries and has been used for outbreak response, according to WHO. Local availability requires confirmation.
TreatmentNo specific antiviral treatment changes the course of acute hepatitis E. Hospital care is required for acute liver failure and should be considered for symptomatic pregnant women.
ReservoirHumans for genotypes 1 and 2; non-human mammals, including pigs, for zoonotic genotypes 3 and 4.
Endemic regionsWorldwide; most common in sub-Saharan Africa and east and south Asia, particularly where safe water and sanitation are limited.

Transmission

Hepatitis E mainly spreads when infected people's stools contaminate water that others drink. Poor sanitation, flooding and disruption of water supplies can allow many people to be exposed to the same source. The virus has several genetic types, called genotypes. Types 1 and 2 primarily infect humans and cause waterborne outbreaks. Types 3 and 4 mainly infect other mammals and can reach people through uncooked or undercooked meat. WHO reports that infected people shed the virus from a few days before illness until 3–4 weeks after it begins. A single reproduction number was not established in the retrieved sources.

Symptoms and severity

Symptoms usually begin 2–10 weeks after exposure, averaging 5–6 weeks. They can include mild fever, poor appetite, nausea, vomiting, abdominal pain, itching, dark urine, pale stools and jaundice. Children often have no symptoms or only mild illness. Most infections resolve within 2–6 weeks, but sudden liver failure can occur. Pregnancy is a major risk factor: WHO reports that up to 20–25% of women infected in the third trimester can die. This is not the risk for everyone with hepatitis E. People taking medicines that suppress immunity, especially organ transplant recipients, can occasionally develop chronic infection. Testing is needed because other diseases can cause similar symptoms.

Treatment and vaccines

WHO states that no specific antiviral treatment changes the course of acute hepatitis E. Most people recover without hospital admission, but those with sudden liver failure need hospital care. Admission should also be considered for pregnant women who have symptoms. WHO advises avoiding unnecessary medicines that can harm the liver, including acetaminophen, also called paracetamol; discuss medicines with a clinician rather than self-treating. A preventive vaccine is licensed in China and other countries and has been used in outbreak response. A large randomized vaccine trial was published in 2010. The retrieved sources do not establish worldwide availability, so local access needs confirmation.

Where it occurs

Hepatitis E occurs worldwide, but WHO identifies sub-Saharan Africa and east and south Asia as the areas where disease is most common. Waterborne outbreaks are closely linked to limited safe drinking water, sanitation and health services. Conflict and displacement can worsen these conditions. WHO's fact sheet says nearly half of outbreaks occur in settings such as refugee camps or camps for internally displaced people. Infection is not confined to camps or to these regions: animal-associated types also cause infections through food. The 2024 Chad outbreak affected both displaced people and the host community, although most reported suspected cases were in camps and transit sites.

Recent history

Open Outbreak's archive contains 11 hepatitis E events, including notices concerning Chad, Sudan, South Sudan, Niger, Nigeria, Namibia and Burkina Faso. These are archive entries, not a complete count of global outbreaks. The latest WHO notice returned in this search was dated 2024-05-08. It reported 2,092 suspected cases and seven deaths in eastern Chad between 2024-01-02 and 2024-04-28; WHO assessed national risk as high, regional risk as moderate and global risk as low. A notice dated 2023-05-05 reported 91 suspected cases, including 35 confirmed cases, and five deaths in Wau, South Sudan. These historical figures do not establish the situation on 2026-11-15.

What to watch

Concerning signals include new clusters of jaundice, spread into additional districts or countries, contaminated water supplies, flooding and worsening sanitation in crowded settlements. Severe illness or deaths among pregnant women deserve particular attention. Laboratory confirmation matters because jaundice alone cannot identify hepatitis E. Investigators should establish whether cases share a water or food source or indicate onward transmission between people. Vaccine access and the ability to deliver vaccination during outbreaks are also important to monitor. The retrieved sources do not document antiviral resistance as a current outbreak driver. For individuals, jaundice or suspected hepatitis E during pregnancy warrants prompt medical assessment.

Updated